According to the US' CDC, the ongoing clade II 2022 mpox outbreak has been responsible for over 100,000 infections in 122 countries to date worldwide.

The inoculation, produced by the Butantan Institute in partnership with Austrian Valneva, had its registration approved this ...

When we think about the protection that can be provided by a comprehensive immunization plan, we think in terms of lifetimes. It’s vital that we also remember the important moments that make up each ...

In February 2024, dairy farmers in Texas began noticing their cows were producing less milk and that the milk was discoloured ...

Last year it won two grants from the Bill & Melinda Gates Foundation worth $6 million towards developing its inactivated polio (IPV) and live attenuated measles rubella (MR) vaccines.

Hexaplex' Vaccine Aims to Boost Flu Protection Feb. 26, 2024 — A research team has developed a recombinant protein flu vaccine candidate. It utilizes a nanoliposome vaccine platform that ...

The interest in using recombinant bacteria as vaccine vectors for active immunotherapy ... This review will focus on the development of live-attenuated and killed strains of the intracellular ...

Shingrix is a recombinant protein subunit-based vaccine and is generally used in favour of an older shingles vaccine – Merck & Co's Zostavax – which is cased on a live, attenuated virus.

The recombinant vaccine, under the brand name Vimkunya, is recommended for persons age 12 and older who are traveling to a country or territory where there is a chikungunya outbreak. The United States ...

At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted on recommendations for several ...